Dianthus Therapeutics, INC. /De/ (DNTH) — DEF 14A Filings

All DEF 14A filings from Dianthus Therapeutics, INC. /De/. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Dianthus Therapeutics DEF 14A: Executive Compensation Details — Apr 10, 2025 Risk: low
Dianthus Therapeutics, Inc. filed a DEF 14A on April 10, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. Key individuals li
Dianthus Therapeutics Announces 2024 Annual Meeting of Stockholders on May 23 — Apr 11, 2024 Risk: low
Dianthus Therapeutics, Inc. /DE/ (DNTH) filed a Proxy Statement (DEF 14A) with the SEC on April 11, 2024. The 2024 Annual Meeting of Stockholders for Dianthus T

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX